Alfred G. Merriweather, Chief Financial Officer at Adamas Pharmaceuticals Inc (ADMS), sold 1,584 shares at $6.91 ($11K) on 2019-09-20, disclosed to the SEC on 2019-09-23.
Open-market sale of $11k ADMS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |